SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001599298-20-000012
Filing Date
2020-06-02
Accepted
2020-06-02 16:03:37
Documents
56
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 6-K a6-kq1march2020xfrontpage1.htm 6-K 31136
2 EXHIBIT 99.1 rns-q1march2020.htm EX-99.1 464139
3 EXHIBIT 99.2 ias34-q1march2020.htm EX-99.2 476232
10 summitmasterrgbjpeg.jpg GRAPHIC 65667
  Complete submission text file 0001599298-20-000012.txt   3689526

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT smmt-20200331.xml EX-101.INS 577137
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20200331.xsd EX-101.SCH 40351
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT smmt-20200331_cal.xml EX-101.CAL 60467
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20200331_def.xml EX-101.DEF 118131
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20200331_lab.xml EX-101.LAB 402200
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20200331_pre.xml EX-101.PRE 219485
Mailing Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB
Business Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB 44-123-544-3939
Summit Therapeutics plc (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0131
Type: 6-K | Act: 34 | File No.: 001-36866 | Film No.: 20936946
SIC: 2834 Pharmaceutical Preparations